Zobrazeno 1 - 10
of 169
pro vyhledávání: '"JOHN A. BOSSO"'
Autor:
John A. Bosso, Isaac F. Mitropoulos, Robert Bergsbaken, Noe Mateo, Craig Harvey, Christopher J. Sullivan, Garry L. Parlier, James Bryan Warren, Mary A. Ullman, John C. Rotschafer
Publikováno v:
Antibiotics, Vol 2, Iss 2, Pp 256-264 (2013)
Regions Hospital started a multidisciplinary antibiotic stewardship program (ASP) in 1998. The program effectively shut down from 2002–2004 as key personnel departed and was then restarted but without the dedicated pharmacist and infectious disease
Externí odkaz:
https://doaj.org/article/d5e18236fd2d491c8d0e3ffef120cafc
What's New in the Diagnosis and Treatment of Aspirin-Exacerbated Respiratory Disease: A Brief Review
Autor:
Jennifer E. Douglas, John V. Bosso
Publikováno v:
American Journal of Rhinology & Allergy. 37:198-206
Background Aspirin-exacerbated respiratory disease (AERD) is a chronic condition characterized by the presence of asthma, chronic rhinosinusitis with nasal polyposis, and sensitivity to aspirin and other non-steroidal anti-inflammatory drugs. Diagnos
Publikováno v:
Otolaryngology Case Reports, Vol 17, Iss , Pp 100225- (2020)
This case report discusses the unusual finding of aural polyps as a manifestation of aspirin-exacerbated respiratory disease (AERD). A 55-year-old patient with a history of AERD, persistent otorrhea, and mixed hearing loss was found to have bilateral
Externí odkaz:
https://doaj.org/article/f75e023b5da04c029205af9f98aba9b4
Autor:
John V. Bosso, MD, FAAAAI
Publikováno v:
World Journal of Otorhinolaryngology-Head and Neck Surgery, Vol 6, Iss 4, Pp 201-202 (2020)
Externí odkaz:
https://doaj.org/article/62c9ddf3bda14ed3b79a81d564701a32
SNOT-22 scores after 6 months of aspirin therapy are predictive of long-term quality of life in AERD
Autor:
Siddhant H. Tripathi, Andrew Corr, Ankur Kumar, Heather Ungerer, Mandy Salmon, Nithin D. Adappa, John V. Bosso
Publikováno v:
Allergy and Asthma Proceedings. 44:78-80
Background: Aspirin exacerbated respiratory disease (AERD) is an inflammatory condition that consists of eosinophilic asthma, chronic rhinosinusitis with nasal polyps, and respiratory reactions to cyclooxygenase-1 inhibitors. Aspirin therapy after as
Autor:
Siddhant H. Tripathi, Heather N. Ungerer, Bianca Rullan‐Oliver, Tapan Patel, Auddie M. Sweis, Ivy W. Maina, Michael A. Kohanski, James N. Palmer, Nithin D. Adappa, John V. Bosso
Publikováno v:
International Forum of Allergy & Rhinology. 12:1299-1302
Autor:
Li Hui Tan, Cailu Lin, Heather Ungerer, Ankur Kumar, Anas Qatanani, Nithin D. Adappa, James N. Palmer, John V. Bosso, Danielle Reed, Noam A. Cohen, Michael A. Kohanski
Publikováno v:
International Forum of Allergy & Rhinology. 12:1232-1241
Patients with aspirin-exacerbated respiratory disease (AERD) are among the most challenging rhinologic patients to treat. AERD has a complex inflammatory milieu of lipid mediators and cytokines. In this study we evaluated cytokine differences in the
Autor:
Elizabeth A, Sell, Li Hui, Tan, Cailu, Lin, John V, Bosso, James N, Palmer, Nithin D, Adappa, Robert J, Lee, Michael A, Kohanski, Danielle R, Reed, Noam A, Cohen
Publikováno v:
International Forum of Allergy & Rhinology.
Succinate, although most famous for its role in the Krebs cycle, can be released extracellularly as a signal of cellular distress, particularly in situations of metabolic stress and inflammation. Solitary chemosensory cells (SCCs) express SUCNR1, the
Autor:
John V. Bosso, Michael T. Werner
Publikováno v:
Allergy and Asthma Proceedings. 42:283-292
Background: Only a fraction of patients with allergic rhinitis receive allergen-specific immunotherapy (AIT). AIT is most commonly delivered subcutaneously in a series of injections over 3‐5 years. Common obstacles to completing this therapy includ
Autor:
Jennifer E. Douglas, Cailu Lin, Corrine J. Mansfield, Katherine Bell, Mandy K. Salmon, Michael A. Kohanski, Nithin D. Adappa, James N. Palmer, John V. Bosso, Danielle R. Reed, Noam A. Cohen
Publikováno v:
International forum of allergyrhinologyREFERENCES.